RESMED INC — Director's Dealing 2013

Sep 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-09-03

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-03	ResMed Common Stock	M	7500	$21.025	Acquired	131891.678	Direct
2013-09-03	ResMed Common Stock	S	7500	$47.507	Disposed	124391.678	Direct
2013-09-03	ResMed Common Stock	S	500	$47.59	Disposed	123891.678	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-03	ResMed Common Stock Options	$21.025	M	7500	Disposed	2014-11-07	ResMed Common Stock (7500)	Direct

Footnotes

F1: This transaction was conducted under a 10b5-1 trading plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F3: This transaction was executed in multiple trades at prices ranging from $47.19 to $47.82. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.